Home › Funds › FOLKETRYGDFONDET › VCRE
FOLKETRYGDFONDET position in VCRE
VICORE PHARMA HLDG AB
FOLKETRYGDFONDET reported holding 972,852 shares of VCRE (VICORE PHARMA HLDG AB) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 0.18% of its reported portfolio and ranking #7 among its reported holdings. FOLKETRYGDFONDET first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How FOLKETRYGDFONDET's VCRE position evolved
FOLKETRYGDFONDET first disclosed a stake in VCRE in Q3 2026 at 972,852 shares (US$9.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 972.85K | $9.25M | New |
About VCRE and 13F data
VCRE (VICORE PHARMA HLDG AB) is a company whose sector is not yet classified in our data. 2 other funds we track also report a position in VCRE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on FOLKETRYGDFONDET
FAQ
How long has FOLKETRYGDFONDET held VCRE?
FOLKETRYGDFONDET has disclosed VCRE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is FOLKETRYGDFONDET's current position in VCRE?
As of Q3 2026, FOLKETRYGDFONDET holds 972.85K shares of VCRE (VICORE PHARMA HLDG AB), valued at $9.25M, representing 0.18% of its reported portfolio and ranking #7.
Has FOLKETRYGDFONDET been buying or selling VCRE?
In the latest 13F filing (Q3 2026), FOLKETRYGDFONDET newly opened its position in VCRE.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.